Dry Eye Disease
📧 Sign up to get email alerts when something new happens for Dry Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Topical Statin Eye Drop in the Management of the Dry Eye [Phase 1, Phase 2]
Clinical trial update for a topical statin eye drop being investigated for dry eye disease across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study) [Phase 3]
Clinical trial update reporting long-term safety and tolerability of NOV03 (perfluorohexyloctane) in adults who completed the Kalahari study…
-
CLINICAL_TRIALS withdrawal · 2023-12-18Clinical Trial Update: Tear Film Markers in Dry Eye Syndrome [Phase 4]
A Phase 4 clinical trial on tear film markers in dry eye syndrome was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia [Phase 2]
A Phase 2 clinical trial assessing diquafosol prophylactic therapy to prevent dry eye disease in cataract surgery patients in Indonesia.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of TL-925 as a Treatment for Dry Eye Disease [Phase 2]
Phase 2 clinical trial update for TL-925 in dry eye disease has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study for the Treatment of Dry Eye in Postmenopausal Women [Phase 2]
Phase 2 trial update for a treatment of dry eye disease in postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease. [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating safety, tolerability, and efficacy of OTX-CSI for dry eye disease has posted results.
-
FDA approval · 2023-11-07FDA Approved: LIFITEGRAST — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for Lifitegrast, a generic treatment for dry eye disease.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease [Phase 3]
Phase 3 trial comparing efficacy of 100% platelet-rich plasma versus 100% serum eye drops in dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye [Phase 3]
Phase 3 trial completed evaluating the efficacy and safety of Tanfanercept (HL036) ophthalmic solution for dry eye disease; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004 [Phase 3]
Phase 3 trial update for CyclASol in dry eye disease has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease [Phase 2]
Phase 2 clinical trial of AXR-159 ophthalmic solution for dry eye disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye [Phase 4]
A Phase 4 clinical trial evaluating 0.05% cyclosporine A eye drops for post-refractive surgery dry eye.
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Efficacy and Safety of USL for Dry Eye Disease [Phase 2]
Phase 2 trial update assessing efficacy and safety of USL for dry eye disease.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease [Phase 2]
Phase 2 trial update on pilocarpine ophthalmic topical cream for dry eye disease and keratoconjunctivitis sicca reports safety and efficacy …
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 1, Phase 2]
Phase 1/2a trial assessing safety and efficacy of ALY688 ophthalmic solution for dry eye disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK) [Phase 3]
Phase 3 investigator-initiated trial evaluating OC-01 (varenicline) nasal spray for dry eye disease after LASIK completed.
-
FDA approval · 2023-05-30FDA Approved: VEVYE — Original Application (Harrow Eye, LLC)
FDA approved VEVYE, a cyclosporine ophthalmic solution, from Harrow Eye, LLC, through its original NDA. It is indicated for the treatment of…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease [Phase 2]
Phase 2 clinical trial updating on safety, tolerability, and efficacy of A197 in subjects with Dry Eye Disease.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of SHR8028 eye drops for dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease [Phase 3]
A Phase 3 clinical trial evaluating OC-01 (varenicline) nasal spray for dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease [Phase 1, Phase 2]
Clinical trial updates on SJP-0132 in dry eye disease show completed Phase 1/2 study with safety, pharmacokinetics, and efficacy data posted…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 2, Phase 3]
Clinical trial update for ALY688 ophthalmic solution in dry eye disease across Phase 2 and Phase 3 shows completed status.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients [Phase 4]
Phase 4 trial update analyzing postoperative ocular surface changes and intervention effects after pars plana vitrectomy in patients with me…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease [Phase 2]
Phase 2 study assessing safety, efficacy, and optimal dosage of K-161 in moderate to severe dry eye disease has completed with results poste…